• IEIE Transactions on Smart Processing and Computing
• /
• 제4권6호
• /
• pp.422-433
• /
• 2015

In this paper, we demonstrate inter-layer prediction tools for scalable video coders. The proposed scalable coder is designed to support not only spatial, quality and temporal scalabilities, but also view scalability. In addition, we propose quad-tree inter-layer prediction tools to improve coding efficiency at enhancement layers. The proposed inter-layer prediction tools generate texture prediction signal with exploiting texture, syntaxes, and residual information from a reference layer. Furthermore, the tools can be used with inter and intra prediction blocks within a large coding unit. The proposed framework guarantees the rate distortion performance for a base layer because it does not have any compulsion such as constraint intra prediction. According to experiments, the framework supports the spatial scalable functionality with about 18.6%, 18.5% and 25.2% overhead bits against to the single layer coding. The proposed inter-layer prediction tool in multi-loop decoding design framework enables to achieve coding gains of 14.0%, 5.1%, and 12.1% in BD-Bitrate at the enhancement layer, compared to a single layer HEVC for all-intra, low-delay, and random access cases, respectively. For the single-loop decoding design, the proposed quad-tree inter-layer prediction can achieve 14.0%, 3.7%, and 9.8% bit saving.

• 의료법학
• /
• 제12권1호
• /
• pp.257-285
• /
• 2011

This thesis has studied about the legal characteristic of injection of the trial drug, the position of the pharmaceutical firm as a contractor of the clinical trial, the possibility of compulsory performance of consistent injection of the trial drug, and the damage claim caused in the process of the clinical trial from the viewpoint of protecting the trial subject in the clinical trial. According to court's judgement in the United States, the lawsuit of the trial subject, although the trial subject had expected consistent injections, was dismissed because there was no direct contract between pharmaceutical and trial subject. However, Helsinki Declaration prescribe the medical research as follows. 'All patients who participated in the research should be able to use the best precaution, diagnosis, and treatment proved by the final outcome of the research'. The trial subject is entitled to demand only the pharmaceutical firm which developed and provided the trial drug, and the pharmaceutical firm has the obligation to supply the trial drug to the trial subject. Therefore, it would be not enough to protect the trial subject if the pharmaceutical firm which makes the trial drug is ruled out. In addition, especially, in case the trial drug has a constant effect with the aim of treatment, if the injection of the trial drug is suddenly stopped, the trial subject would not have the benefit of treatment by the trial drug. In this case, the best remedy against the damage is to urge a constant injection of the trial drug. Thus, in certain case, it is reasonable to consider that the pharmaceutical firm has the obligation to supply the trial drug to the trial subject constantly, and it is also necessary to compel it through effective means in case the pharmaceutical firm do not fulfill its obligation to supply the trial drug. However, as an essential prerequisite for the assertion mentioned above, it should be judged under the principle of good faith considering the concrete situation, that is, what roles the pharmaceutical firm has played.

• 한국화재소방학회논문지
• /
• 제28권2호
• /
• pp.48-53
• /
• 2014

본 연구에서는 운동장과 건물의 옥상 등 실외에 설치되고 있는 인조잔디에 대해 국내 기준에 의한 화재위험성을 평가하고자 한다. 현재 인조잔디에 대한 국내 기준은 실외에 한하고 있으며 특히 학교체육시설이라고 국한하여 KS M 3888-1에 강제하고 있고, 실내 기준은 소방방재청고시(2012-35호)에 권장사항으로 규정하고 있다. 이에 본 연구는 강제규정하고 있는 실외에 설치되는 인조잔디에 국한하여 연소시험을 진행하였다. $45^{\circ}$ 방염시험을 진행하여 분석한 결과, 현재 설정되어 있는 기준이 화재의 위험성을 판단하기에 매우 미흡함을 확인하였다. 이에 바닥재로 통용되고 있는 방염처리된 카페트의 연소시험을 통해 그 특징을 비교한 후 분석하였다. 45o 방염시험기를 이용하여 착화성을 시험한 후 평가한 결과, 해당기준에서 크게 벗어난 인조잔디와 달리 카페트는 방염성능기준을 만족하였다. 이에 추가로 인조잔디에 대해 콘칼로리미터시험을 진행하여 착화 이후의 연소특성을 분석 및 평가함으로써 실외 적용되는 인조잔디의 기준 강화를 위한 대책을 제안하였다.